Tacrolimus
- All
- News
-
Stocks To Watch: Wipro,Biocon,TVS Motor Company
Biocon shares may witness some action after the pharma company expanded its generic formulations portfolio, with the launch of tacrolimus capsules in the United States.
-
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
-
New Research May Lead to Birth Control 'Pill' for Men
Two drugs that help suppress the immune system in organ transplant patients may lead to a birth control "pill" for men that works by inhibiting the sperms' ability to penetrate an egg, a new study has found.
-
Stocks To Watch: Wipro,Biocon,TVS Motor Company
Biocon shares may witness some action after the pharma company expanded its generic formulations portfolio, with the launch of tacrolimus capsules in the United States.
-
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
-
New Research May Lead to Birth Control 'Pill' for Men
Two drugs that help suppress the immune system in organ transplant patients may lead to a birth control "pill" for men that works by inhibiting the sperms' ability to penetrate an egg, a new study has found.
